Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 may be associated with long-term adverse effects such as cytopenia and immune deficiency. In order to characterize these late events, we analyzed 31 patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene cilo...

Descripción completa

Detalles Bibliográficos
Autores principales: Strati, Paolo, Varma, Ankur, Adkins, Sherry, Nastoupil, Loretta J., Westin, Jason R., Hagemeister, Fredrick B, Fowler, Nathan H, Lee, Hun J., Fayad, Luis E., Samaniego, Felipe, Ahmed, Sairah, Chen, Yiming, Horowitz, Sandra, Arafat, Sara, Johncy, Swapna, Kebriaei, Partow, Mulanovich, Victor Eduardo, Heredia, Ella Ariza, Neelapu, Sattva S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485681/
https://www.ncbi.nlm.nih.gov/pubmed/32732355
http://dx.doi.org/10.3324/haematol.2020.254045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485681/
https://www.ncbi.nlm.nih.gov/pubmed/32732355
http://dx.doi.org/10.3324/haematol.2020.254045

Ejemplares similares